Article
Dermatology
Istemi Serin, Mehmet Hilmi Dogu
Summary: The study demonstrated the superior diagnostic performance of LFA in diagnosing invasive aspergillosis, suggesting combining multiple methods for a better early diagnosis.
Article
Immunology
F. Lamoth, H. Akan, D. Andes, M. Cruciani, O. Marchetti, L. Ostrosky-Zeichner, Z. Racil, C. J. Clancy
Summary: BDG testing may be useful for diagnosing IF, but its performance and utility vary depending on patient population and pretest likelihood of IF.
CLINICAL INFECTIOUS DISEASES
(2021)
Article
Infectious Diseases
Maria Siopi, Stamatis Karakatsanis, Christoforos Roumpakis, Konstantinos Korantanis, Elina Eldeik, Helen Sambatakou, Nikolaos Sipsas, Maria Pagoni, Maria Stamouli, Panagiotis Tsirigotis, Joseph Meletiadis
Summary: This study evaluated the performance of the Dynamiker (R) Fungus (1-3)-beta-D-glucan assay (DFA) for diagnosing invasive aspergillosis (IA) and found that it was highly consistent with the well-established Fungitell (R) assay (FA). The study also found that using consecutive positive samples as the criterion for diagnosing IA improved the negative predictive value in high-risk patients with hematologic malignancies.
INFECTIOUS DISEASES AND THERAPY
(2022)
Article
Infectious Diseases
Jian Guo, Chenlu Xiao, Wenjie Tian, Li Lv, Liang Hu, Lijun Ni, Dongjiang Wang, Wei Li, Dan Qiao, Wenjuan Wu
Summary: The diagnostic performance of lateral flow assay (LFA) and enzyme-linked immunosorbent assay (ELISA) to detect Aspergillus Galactomannan levels in serum and bronchoalveolar lavage fluid (BALF) samples was compared in this multicenter study. The results showed that LFA demonstrated excellent performance in diagnosing Aspergillus infection and can be used as an early diagnostic tool.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
(2023)
Article
Dermatology
Bertrand Nyuykonge, Emmanuel Siddig, Najwa A. Mhmoud, Sahar Bakhiet, Eduard Zijlstra, Annelies Verbon, Ahmed H. Fahal, Wendy W. J. van de Sande
Summary: This study compared the performance of Wako and Fungitell beta-D-glucan assays in patients with eumycetoma. The results showed that when using the optimized cut-off value, the Wako assay and Fungitell assay had comparable performance in terms of sensitivity and specificity. Therefore, the Wako assay can be used in combination with current diagnostic tools.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
(2023)
Article
Microbiology
Siobhan O'Regan, Brendan O'Kelly, Paul Reidy, Aoibhlinn O'Toole, John Caird, Cora McNally, Samuel McConkey, Eoghan de Barra
Summary: This case describes the successful treatment of a cervical spinal cord Aspergillus fumigatus infection in an immunocompromised patient using (1,3)-beta-D glucan guidance. The patient, who was immunocompromised due to steroid and anti-TNF therapy as well as underlying conditions, underwent neurosurgical intervention and received prolonged antifungal therapy, resulting in clinical cure.
Article
Medicine, General & Internal
Zhang Dai, Minjing Cai, Yihui Yao, Jianhui Zhu, Lingqing Lin, Lili Fang, Zhimeng Li, Huochun Yi, Bo Chen, Xianming Liang
Summary: This study evaluated the diagnostic performance of bronchoalveolar lavage fluid (BALF) galactomannan (GM) in non-neutropenic respiratory disease patients with invasive pulmonary aspergillosis (IPA), and found that BALF GM outperforms other biomarkers in diagnosis with an optimal cutoff value of 0.6.
Review
Microbiology
Malcolm A. Finkelman
Summary: (1 -> 3)-beta-glucan (BDG) testing has been used as an adjunct in the diagnosis of invasive fungal disease (IFD) for nearly three decades, showing high negative predictive value but potential false positives due to contamination and mucosal barrier injury. Understanding non-IFD causes of elevated circulating BDG, such as iatrogenic contamination and Nocardia sp. infection, can improve the planning and interpretation of BDG assays.
Review
Microbiology
Laura Ferreras-Antolin, Andrew Borman, Antonia Diederichs, Adilia Warris, Thomas Lehrnbecher
Summary: This study aimed to analyze the available data on the use of serum BDG in neonates and immunocompromised children and adolescents, as well as to understand the extent and characteristics of the use of BDG in children in Europe.
Article
Immunology
Nuri Lee, Dohern Kym
Summary: This study evaluates the predictability of (1,3)-beta-D-glucan (BD) assay in predicting invasive candidiasis (IC) in patients with severe burn injuries. The optimal cut-off value for BD is found to be 124.7 pg/mL, and BD is identified as an independent predictor for IC. Patients with a BD level between 120 and 150 pg/mL have a higher risk of IC occurrence.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
(2022)
Article
Microbiology
P. Lewis White, Jessica S. Price, Matthijs Backx
Summary: During the COVID-19 pandemic, the use of BDG testing, particularly with the STAT assay, has shown promise in enhancing the diagnosis of IFD in critical care. The STAT assay demonstrated good agreement with the FA in terms of sensitivity and specificity, providing a simpler alternative for BDG detection. This increased accessibility to BDG testing through the STAT assay is beneficial, especially during the ongoing pandemic situation.
JOURNAL OF CLINICAL MICROBIOLOGY
(2021)
Article
Microbiology
Shreya Singh, Rimjhim Kanaujia, Sourav Agnihotri, Harsimran Kaur, Arunaloke Chakrabarti, Shivaprakash M. Rudramurthy
Summary: The Fujifilm Wako assay shows promise as a valuable alternative to the Fungitell assay for diagnosing invasive fungal disease (IFD), with good sensitivity, specificity, and agreement. It also has a shorter run-time and faster results.
Article
Infectious Diseases
Alexandre Alanio, Maud Gits-Muselli, Nicolas Guigue, Blandine Denis, Anne Bergeron, Sophie Touratier, Samia Hamane, Stephane Bretagne
Summary: Comparison of two commercial kits for serum (1 -> 3)-beta-D-glucan (BDG) testing in patients showed similar performance, with both assays providing good sensitivity and specificity when using optimized thresholds.
Review
Infectious Diseases
Cornelia Lass-Floerl, Eldina Samardzic, Miriam Knoll
Summary: This review provides an updated inventory of fungal antigen and serology tests in 2021, with a focus on Aspergillus, Candida, and Cryptococcus species. Antigen assays like GM and beta-D-glucan detection systems are frequently used for diagnosing invasive and chronic fungal infections, but their sensitivity and specificity vary depending on various factors.
CLINICAL MICROBIOLOGY AND INFECTION
(2021)
Article
Microbiology
Sarfaraz Ahmad Ejazi, Somsubhra Thakur Choudhury, Anirban Bhattacharyya, Mohd Kamran, Krishna Pandey, Vidya Nand Ravi Das, Pradeep Das, Fernando Oliveira da Silva, Dorcas Lamounier Costa, Carlos Henrique Nery Costa, Mehebubar Rahaman, Rama Prosad Goswami, Nahid Ali
Summary: Visceral leishmaniasis (VL), a fatal parasitic infection, is neglected among tropical diseases, and diagnosis using lateral flow assay (LFA) for anti-Leishmania antibodies shows high sensitivity and specificity in Indian and Brazilian patients. LFA is rapid, simple, and suitable for field usage, providing an alternative for VL diagnosis in settings where tissue aspiration is difficult.